Progressive Hearing Loss in Childhood: A Prognostic Factor Systematic Review
5 affiliations
- 1Audiology Department, Imperial College Healthcare NHS Trust, London, UK
- 2Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
- 3Paediatric ENT Department, Royal Manchester Children’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK
- 4Manchester University NHS Foundation Trust, Manchester, UK
- 5Hearing Health Theme, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, UK
Abstract
Introduction: Progressive hearing loss (PHL) in childhood can significantly impact speech, language, and educational outcomes. While congenital and acquired aetiological factors for PHL are well documented, their influence on hearing deterioration and the trajectory of PHL remains unclear. Understanding prognostic factors is essential to enable targeted surveillance and timely intervention.
Methods: A PROSPERO-registered systematic review (ID: CRD42023492129) was conducted to identify and evaluate prognostic factors associated with childhood PHL. MEDLINE, EMBASE, and Cochrane Library databases were searched for studies published between 2000 and 2025 in English, including patients aged 0–18 years, with confirmed permanent hearing loss. Study design quality was assessed using CHARMS-PF, and risk of bias was evaluated with QUIPS (Quality in Prognosis Factor Studies). Due to heterogeneity in definitions and outcomes, a narrative synthesis was performed.
Results: Eighteen (participants n = 1,497) studies were included in the narrative synthesis and eligible for risk of bias assessment; only 2 were deemed low risk. Exploratory prognostic factors included congenital cytomegalovirus infection, enlarged vestibular aqueduct, platinum-based chemotherapy, and radiotherapy. The influence of these factors on the rate and severity of hearing loss was variable, and current evidence was insufficient for meta-analysis or definitive prognostic conclusions.
Conclusion: Evidence on prognostic factors for PHL is limited and heterogeneous. High-quality, methodologically robust studies are needed to confirm these factors and develop predictive, multivariable models. Such models could guide personalised surveillance and intervention strategies, enabling clinicians to deliver the right intervention at the optimal time and improving long-term auditory and developmental outcomes for children at risk of PHL.
Related
- The mouse Cdh23ahl allele drives early cochlear dysfunction and phenotypic heterogeneity before progressive hearing loss
- Knowledge and attitude among the mothers of children in age group 1–5 years regarding childhood hearing loss
- The Role of Cochlear Anatomy in Hearing Preservation After Cochlear Implantation in Adults: A Systematic Review
- Tooth wear and socioeconomic status in childhood and adulthood: Findings from a systematic review and meta-analysis of observational studies
- Cochlear Implants Versus Hearing Aids in Children With Auditory Neuropathy Spectrum Disorder: A Systematic Review
BibTeX
@article{dempsey2026progressive,
title = {{Progressive Hearing Loss in Childhood: A Prognostic Factor Systematic Review}},
author = {James Dempsey and Nathan Richard Walker and Michael Lawrence and Callum Shields and Glen P. Martin and Karolina Kluk and Iain A. Bruce and Jaya R. Nichani},
journal = {Audiology \& Neurotology},
year = {2026},
month = oct,
doi = {10.1159/aud/abnag013},
url = {https://doi.org/10.1159/aud/abnag013},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Progressive Hearing Loss in Childhood: A Prognostic Factor Systematic Review
AU - James Dempsey
AU - Nathan Richard Walker
AU - Michael Lawrence
AU - Callum Shields
AU - Glen P. Martin
AU - Karolina Kluk
AU - Iain A. Bruce
AU - Jaya R. Nichani
PY - 2026
DA - 2026/10/05
JO - Audiology & Neurotology
DO - 10.1159/aud/abnag013
UR - https://doi.org/10.1159/aud/abnag013
AB - Introduction: Progressive hearing loss (PHL) in childhood can significantly impact speech, language, and educational outcomes. While congenital and acquired aetiological factors for PHL are well documented, their influence on hearing deterioration and the trajectory of PHL remains unclear. Understanding prognostic factors is essential to enable targeted surveillance and timely intervention. Methods: A PROSPERO-registered systematic review (ID: CRD42023492129) was conducted to identify and evaluate prognostic factors associated with childhood PHL. MEDLINE, EMBASE, and Cochrane Library databases were searched for studies published between 2000 and 2025 in English, including patients aged 0–18 years, with confirmed permanent hearing loss. Study design quality was assessed using CHARMS-PF, and risk of bias was evaluated with QUIPS (Quality in Prognosis Factor Studies). Due to heterogeneity in definitions and outcomes, a narrative synthesis was performed. Results: Eighteen (participants n = 1,497) studies were included in the narrative synthesis and eligible for risk of bias assessment; only 2 were deemed low risk. Exploratory prognostic factors included congenital cytomegalovirus infection, enlarged vestibular aqueduct, platinum-based chemotherapy, and radiotherapy. The influence of these factors on the rate and severity of hearing loss was variable, and current evidence was insufficient for meta-analysis or definitive prognostic conclusions. Conclusion: Evidence on prognostic factors for PHL is limited and heterogeneous. High-quality, methodologically robust studies are needed to confirm these factors and develop predictive, multivariable models. Such models could guide personalised surveillance and intervention strategies, enabling clinicians to deliver the right intervention at the optimal time and improving long-term auditory and developmental outcomes for children at risk of PHL.
SN - 1420-3030
SN - 1421-9700
ER -